Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Int J Cardiol. 2018 Oct 15;269:27-30. doi: 10.1016/j.ijcard.2018.06.108. Epub 2018 Jun 28.
Vasospastic angina (VSA), which often causes acute coronary syndrome (ACS), can be diagnosed by intracoronary acetylcholine (ACh) provocation test. However, the safety and usefulness of ACh provocation test in ACS patients on emergency coronary angiography (CAG) compared to non-emergency settings are unclear.
A total of 529 patients undergoing ACh provocation test during emergency or non-emergency CAG were included. Patients with resuscitated cardiac arrest were excluded. The primary endpoint was adverse events defined as a composite of death, ventricular fibrillation or sustained ventricular tachycardia, myocardial infarction, cardiogenic shock, cardiac tamponade, and stroke within 24 h after ACh provocation test.
There were no significant differences of the clinical characteristics between the groups of emergency (n = 84) and non-emergency (n = 445) ACh provocation test. The rate of positive ACh provocation test was similar between the 2 groups (50% vs. 49%, p = 0.81). Similarly, the incidence of adverse events in patients with emergency and non-emergency ACh provocation test did not significantly differ (1.2% vs. 1.3%, p = 1.00).
ACh provocation test can be safely performed in ACS patients with no obstructive culprit lesions on emergency CAG, and may be useful to diagnose VSA in those patients.
血管痉挛性心绞痛(VSA)常引起急性冠状动脉综合征(ACS),可通过冠状动脉内乙酰胆碱(ACh)激发试验来诊断。然而,在紧急冠状动脉造影(CAG)和非紧急情况下进行 ACh 激发试验对 ACS 患者的安全性和有效性尚不清楚。
共纳入 529 例行 ACh 激发试验的患者,其中包括紧急和非紧急 CAG。排除心脏骤停复苏患者。主要终点为 ACh 激发试验后 24 小时内发生的死亡、心室颤动或持续性室性心动过速、心肌梗死、心源性休克、心脏压塞和卒中的复合不良事件。
两组(紧急组 n=84 和非紧急组 n=445)的临床特征无显著差异。两组 ACh 激发试验阳性率相似(50% vs. 49%,p=0.81)。同样,两组中接受紧急和非紧急 ACh 激发试验的患者不良事件的发生率也无显著差异(1.2% vs. 1.3%,p=1.00)。
在紧急 CAG 无阻塞性罪犯病变的 ACS 患者中可以安全地进行 ACh 激发试验,且可能有助于诊断这些患者的 VSA。